Intraocular Melanoma Terminated Phase 1 Trials for GP-100 antigen (DB14800)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005841Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaTreatment